Latest / Razib Khan's Unsupervised Learning / Christina Buttons: navigating the gender wars
Transcript
- 0:00SPEAKER_00: This podcast is brought to you by the Albany Public Library Main Branch and the
- 0:04SPEAKER_00: generosity of listeners like you.
- 0:09SPEAKER_00: What is a podcast?
- 0:16SPEAKER_00: God, Daddy, these people talk as much as I do.
- 0:26SPEAKER_00: Razeeb Khan's Unsupervised Learning
- 0:28SPEAKER_01: Even if you and your partner are healthy,
- 0:30SPEAKER_01: there's still a chance your child can develop a serious genetic disease.
- 0:33SPEAKER_01: This is because every embryo has new changes not present in either parent.
- 0:36SPEAKER_01: Most of the time, these are benign, but sometimes they can be catastrophic.
- 0:40SPEAKER_01: Orkin's whole genome embryo reports directly screen the embryo and analyze these de
- 0:44SPEAKER_01: novo genetic mutations.
- 0:46SPEAKER_01: Discuss embryo screening and IVF with a genetics expert.
- 0:50SPEAKER_01: Hey everybody, it's Razeeb with the Unsupervised Learning Podcast.
- 0:53SPEAKER_01: And today I am going to be recording a podcast with someone who is something of a
- 1:01SPEAKER_01: savant about gender ideology and all the controversial trans stuff that's in the news.
- 1:08SPEAKER_01: My friend Christina Buttons,
- 1:10SPEAKER_01: who also has Substack Buttons Lives and is a freelance journalist and has worked at
- 1:15SPEAKER_01: various outfits.
- 1:17SPEAKER_01: And
- 1:18SPEAKER_01: I'm not exaggerating.
- 1:20SPEAKER_01: Christina's head is packed full with a lot of information.
- 1:25SPEAKER_01: Some of it, which I've told her, I would rather not know.
- 1:30SPEAKER_01: She does not look away from painful facts.
- 1:34SPEAKER_01: Or painful surgeries.
- 1:35SPEAKER_01: That's really what I'm talking about.
- 1:36SPEAKER_01: If you follow her on social media,
- 1:38SPEAKER_01: just expect that she's going to give you the unvarnished truth of what's happening.
- 1:42SPEAKER_01: You're not going to censor too much.
- 1:44SPEAKER_01: You don't want to look at that timeline sometimes.
- 1:47SPEAKER_01: But it's an important topic.
- 1:49SPEAKER_01: It's an important question.
- 1:51SPEAKER_01: Um,
- 1:52SPEAKER_01: and obviously it's not something,
- 1:54SPEAKER_01: uh,
- 1:54SPEAKER_01: and,
- 1:55SPEAKER_01: uh,
- 1:55SPEAKER_01: you know,
- 1:56SPEAKER_01: uh,
- 1:56SPEAKER_01: I've talked about this with our mutual friend,
- 1:58SPEAKER_01: Colin Wright,
- 1:59SPEAKER_01: uh,
- 2:00SPEAKER_01: who Christina knows very well.
- 2:01SPEAKER_01: Uh, so, uh, but, uh, Christina has a somewhat different, uh,
- 2:07SPEAKER_01: angle on it,
- 2:08SPEAKER_01: I feel,
- 2:08SPEAKER_01: although she might disagree with me,
- 2:09SPEAKER_01: I feel like she's really focused on details of specific issues,
- 2:14SPEAKER_01: call it an evolutionary biologist,
- 2:17SPEAKER_01: has to deal with some of the philosophical issues about what gender ideology is,
- 2:22SPEAKER_01: and
- 2:23SPEAKER_01: the sex binary and all that.
- 2:25SPEAKER_01: I'm sure they're in alignment on that.
- 2:26SPEAKER_01: But she knows a lot of specific things that are happening in policy, in government, in bureaucracies.
- 2:36SPEAKER_01: And so I want to start there.
- 2:39SPEAKER_01: I want to know what the cash review is.
- 2:40SPEAKER_01: I see it in the news.
- 2:42SPEAKER_01: I read a paragraph here, a paragraph there.
- 2:44SPEAKER_01: There's something called WPATH, acronyms.
- 2:49SPEAKER_01: It's all like a big alphabet soup to me.
- 2:51SPEAKER_01: So Christina, kind of unpack it for us.
- 2:54SPEAKER_00: Hi, thanks for having me, Razeeb.
- 2:57SPEAKER_00: So in April,
- 2:59SPEAKER_00: we saw the release of a four-year investigation into the UK's National Health
- 3:06SPEAKER_00: Service's gender identity issue.
- 3:10SPEAKER_00: clinic for youth that's their like publicly funded clinic um uh the cast review and
- 3:20SPEAKER_00: the associated systematic evidence reviews they basically represent like the most
- 3:24SPEAKER_00: thorough appraisal of pediatric gender medicine to date and across every
- 3:31SPEAKER_00: intervention they found remarkably weak evidence um for for gender transitions and
- 3:37SPEAKER_00: minors um
- 3:40SPEAKER_01: So a cast review is – so this is in Britain.
- 3:43SPEAKER_01: Europe is a little ahead in certain things.
- 3:46SPEAKER_01: And in terms of gender transitions,
- 3:48SPEAKER_01: I think what you're getting at here is there was the quote or the saying,
- 3:55SPEAKER_01: do you want a – for example,
- 3:58SPEAKER_01: do you want a living –
- 4:01SPEAKER_01: a living daughter or a dead son, these suicides.
- 4:07SPEAKER_01: And so gender transition is basically a way to alleviate dysmorphia, right?
- 4:13SPEAKER_01: And obviously, that is supposed to help with mental health.
- 4:18SPEAKER_01: And so you have these youth often who are undergoing legitimate mental distress,
- 4:26SPEAKER_01: and gender transition is a way to alleviate that,
- 4:28SPEAKER_01: right?
- 4:28SPEAKER_01: That's the theory.
- 4:30SPEAKER_00: Right.
- 4:30SPEAKER_00: So in Britain,
- 4:33SPEAKER_00: because the Gender Identity Development Service,
- 4:39SPEAKER_00: GIDS,
- 4:40SPEAKER_00: was a sort of publicly funded institution,
- 4:43SPEAKER_00: we did have access to some data there.
- 4:48SPEAKER_00: In 2008 or something like that, there were about 70 patients.
- 4:55SPEAKER_00: These are adolescents seeking gender clinic services.
- 4:59SPEAKER_00: By the end of the CAS review, it was something like 8,000 or 9,000.
- 5:03SPEAKER_00: It represents a significant increase in adolescents seeking those services.
- 5:13SPEAKER_00: which has caused alarm for a lot of people,
- 5:16SPEAKER_00: which is one of the reasons why this evidence review was conducted in the first place.
- 5:23SPEAKER_00: And they found that for many of these youth, they're experiencing a transient childhood.
- 5:30SPEAKER_00: phase is what they referred to it as,
- 5:32SPEAKER_00: and that they indicated that psychotherapy is the best intervention for them,
- 5:39SPEAKER_00: not medical interventions.
- 5:41SPEAKER_00: So we're seeing a lot of countries in the UK who are rolling back and heavily
- 5:48SPEAKER_00: restricting access to medical interventions.
- 5:51SPEAKER_00: So they're prioritizing therapy instead.
- 5:55SPEAKER_00: But that's not happening in the United States.
- 5:57SPEAKER_00: The U.S.
- 5:58SPEAKER_00: medical organizations,
- 6:00SPEAKER_00: they've all sort of doubled down on their position that,
- 6:04SPEAKER_00: you know,
- 6:04SPEAKER_00: gender-affirming care is evidence-based and necessary and life-saving.
- 6:09SPEAKER_00: But none of these things are true.
- 6:13SPEAKER_00: They're not abiding by the principles of evidence-based medicine,
- 6:17SPEAKER_00: systematic evidence reviews,
- 6:19SPEAKER_00: which represent the pinnacle of evidence-based medicine.
- 6:22SPEAKER_00: They've all found that there is no good evidence to support medically transitioning minors.
- 6:30SPEAKER_01: Yeah, so obviously therapy, we know what that is.
- 6:36SPEAKER_01: You talk to someone, there's discussions back and forth.
- 6:41SPEAKER_01: Medical transition.
- 6:43SPEAKER_01: Tell us – this is stuff – I'm not going to lie, listener.
- 6:47SPEAKER_01: This is stuff I avoid digging deep into or thinking about.
- 6:51SPEAKER_01: But for this podcast, I will go there because sometimes you need to know what the terms actually mean.
- 7:00SPEAKER_01: So medical transition is very clinical, and it detaches you from what's going on.
- 7:07SPEAKER_01: So what is medical transition?
- 7:09SPEAKER_01: I'm assuming hormones, maybe surgeries.
- 7:11SPEAKER_00: Yeah.
- 7:13SPEAKER_00: For small children, the beginning of a transition is a social transition.
- 7:19SPEAKER_00: It includes changing your name and pronouns and your outer appearance.
- 7:25SPEAKER_00: And then this sort of preps them for the first stages of puberty,
- 7:30SPEAKER_00: Tanner stage two,
- 7:31SPEAKER_00: which can be different for different
- 7:34SPEAKER_00: It could be 8, 9, 10, 11.
- 7:37SPEAKER_00: This is when they administer puberty blockers,
- 7:42SPEAKER_00: which have long been said to be reversible,
- 7:45SPEAKER_00: but there's new evidence finding that that's not true at all.
- 7:49SPEAKER_00: They say that's just a pause button on puberty,
- 7:52SPEAKER_00: but almost 98% of the time,
- 7:55SPEAKER_00: they go on to cross-sex hormones.
- 7:58SPEAKER_00: And if you...
- 7:59SPEAKER_00: go from you know puberty blockers to cross-sex hormones uh and if you had if you
- 8:06SPEAKER_00: started puberty blockers at tanner stage two it will like guarantee sterility um
- 8:12SPEAKER_00: and cross-sex hormones have a lot of other medical you know consequences associated
- 8:19SPEAKER_00: with them um
- 8:21SPEAKER_01: All right, really quickly, really quickly.
- 8:24SPEAKER_01: So cross-sex hormones,
- 8:25SPEAKER_01: that would mean born male,
- 8:26SPEAKER_01: biological male,
- 8:28SPEAKER_01: puberty blocker obviously stops the masculinization of the face,
- 8:32SPEAKER_01: facial hair,
- 8:33SPEAKER_01: whatever.
- 8:33SPEAKER_01: Okay, I get that.
- 8:35SPEAKER_01: And the cross-sex hormone is that you put them on estrogen to feminize them.
- 8:38SPEAKER_01: Is that what you're talking about?
- 8:39SPEAKER_00: Yes.
- 8:40SPEAKER_00: And then for adolescent girls, they're put on testosterone.
- 8:45SPEAKER_01: Yeah.
- 8:46SPEAKER_01: I'm going to interrupt.
- 8:49SPEAKER_01: I'm sorry.
- 8:49SPEAKER_01: I have a question here.
- 8:50SPEAKER_01: I don't dig deep into this stuff.
- 8:53SPEAKER_01: Let's set aside – we could talk about the surgeries.
- 8:57SPEAKER_01: We could talk about that.
- 8:58SPEAKER_01: But when it comes to the hormones, as you know, I have a background as a biologist.
- 9:03SPEAKER_01: I'm not a very mechanistic-oriented person with physiology and all this stuff, development, but –
- 9:09SPEAKER_01: It never really honestly struck me as intuitively plausible that you could stop a
- 9:15SPEAKER_01: important developmental function like puberty,
- 9:19SPEAKER_01: do cross-sex hormones,
- 9:21SPEAKER_01: which are massively transformative,
- 9:24SPEAKER_01: and then somehow reverse it.
- 9:27SPEAKER_01: Can you explain to me how that was plausible as something you would claim?
- 9:33SPEAKER_01: Because it seems like you would assume that it's not reversible.
- 9:37SPEAKER_00: Well,
- 9:37SPEAKER_00: puberty blockers have been used in children who have started puberty extremely early,
- 9:46SPEAKER_00: way too early,
- 9:46SPEAKER_00: like six or seven or eight years old.
- 9:49SPEAKER_01: That's a condition.
- 9:50SPEAKER_01: There are conditions that do that.
- 9:51SPEAKER_00: Exactly.
- 9:52SPEAKER_00: And so puberty blockers have been found to be generally safe to use in this
- 9:59SPEAKER_00: population because they're only sort of delaying puberty for a few years.
- 10:02SPEAKER_00: They're not stopping it at this critical time during growth and development.
- 10:09SPEAKER_00: So studies that have found that it's safe to use puberty blockers for precocious puberty are,
- 10:16SPEAKER_00: Sure.
- 10:16SPEAKER_00: But there have been no studies that have found that have been completely safe to
- 10:21SPEAKER_00: use in youths who are experiencing gender dysphoria.
- 10:27SPEAKER_00: And no long-term data exists to support their use in that context.
- 10:32SPEAKER_00: So that is where the belief that they were reversible came from, but really it's out of context.
- 10:41SPEAKER_01: Yeah, so just like reiterate, like kind of explicit what's going on here.
- 10:45SPEAKER_01: So, you know, precocious puberty is a thing.
- 10:49SPEAKER_01: Often these kids – this isn't just like a little early or a little late.
- 10:55SPEAKER_01: Like we're talking, you know, as you said, early elementary school.
- 10:59SPEAKER_01: Often they grow really fast.
- 11:00SPEAKER_01: I've read some articles about males who've undergone this.
- 11:04SPEAKER_01: They get really tall.
- 11:05SPEAKER_01: They get a little facial hair.
- 11:06SPEAKER_01: But their actual final height is actually quite short.
- 11:10SPEAKER_01: You really should not be going into puberty when you're six years old.
- 11:14SPEAKER_01: And so there's a legit medical reason to delay it until you're more biologically mature.
- 11:23SPEAKER_01: I don't know what term would you use to actually start going through all the bodily
- 11:27SPEAKER_01: changes of puberty around 10 to 14.
- 11:30SPEAKER_01: Let's put it in that – just to give a big range here.
- 11:34SPEAKER_01: Okay.
- 11:36SPEAKER_01: So obviously that's in this very specific medical context relating to a – I'm going
- 11:42SPEAKER_01: to call it dysfunctional disorder of puberty.
- 11:45SPEAKER_01: And then with the puberty blocking in this context of gender transition,
- 11:50SPEAKER_01: what you're talking about is taking a child who's undergoing normal physiological
- 11:56SPEAKER_01: and developmental path,
- 11:59SPEAKER_01: but it's – at least they're reporting psychological distress,
- 12:05SPEAKER_01: actually –
- 12:07SPEAKER_01: It's disrupting the normal path of development.
- 12:10SPEAKER_01: And to me,
- 12:12SPEAKER_01: again,
- 12:12SPEAKER_01: that seems a little ridiculous that you would think,
- 12:14SPEAKER_01: oh,
- 12:15SPEAKER_01: well,
- 12:15SPEAKER_01: it's just like with precocious – you know what I'm saying?
- 12:18SPEAKER_01: Precocious purity.
- 12:18SPEAKER_01: It's just like this isn't like a Lego block system where you just like put it
- 12:22SPEAKER_01: together and you can disassemble and reassemble.
- 12:25SPEAKER_01: But that's just my impression.
- 12:27SPEAKER_00: Yeah, I mean, that's correct.
- 12:29SPEAKER_00: I reported on a study earlier this year that found...
- 12:33SPEAKER_00: A Mayo Clinic study that found severe atrophy in the testes of boys on puberty blockers.
- 12:41SPEAKER_00: And this wasn't really known before.
- 12:44SPEAKER_00: But it also causes, you know...
- 12:47SPEAKER_00: decreases in bone mass and sometimes cognitive delays, sometimes psychiatric issues.
- 12:55SPEAKER_00: There's just a lot we don't know because we don't have any robust data on this.
- 13:03SPEAKER_01: And so in a way,
- 13:04SPEAKER_01: there's almost an ethical conundrum where people don't want to do a randomized
- 13:09SPEAKER_01: field test where you just assign some boys to the blockers and some boys not,
- 13:13SPEAKER_01: and track them because let's say you have a huge data set of boys or girls that
- 13:20SPEAKER_01: underwent puberty blockers,
- 13:21SPEAKER_01: and it turns out that it's a massive problem the rest of their life.
- 13:24SPEAKER_01: Well, what have you just done, right?
- 13:27SPEAKER_01: So we're kind of stuck in a...
- 13:30SPEAKER_01: I don't want to say no man's land or just like,
- 13:31SPEAKER_01: you know,
- 13:33SPEAKER_01: it's a doers,
- 13:33SPEAKER_01: you know,
- 13:34SPEAKER_01: damned if you do,
- 13:35SPEAKER_01: damned if you don't.
- 13:35SPEAKER_01: But it does feel like that with some of this stuff because it's kind of like you're
- 13:41SPEAKER_01: experimenting on humans,
- 13:42SPEAKER_01: right?
- 13:43SPEAKER_00: Yeah.
- 13:44SPEAKER_00: And speaking of ethics,
- 13:47SPEAKER_00: like that is sort of been the justification all along from activists and from the
- 13:55SPEAKER_00: scientific and medical organizations sympathetic to the activist narratives is that,
- 13:59SPEAKER_00: you know,
- 13:59SPEAKER_00: if we deprive these children of these medical interventions,
- 14:03SPEAKER_00: they're going to kill themselves because they're
- 14:06SPEAKER_00: this group of kids has, you know, high rates of suicidal thoughts.
- 14:13SPEAKER_00: But when you, you know, these are just, these are kids who have psychiatric issues anyway.
- 14:21SPEAKER_00: There's no good evidence to support that.
- 14:25SPEAKER_00: Not giving them medical interventions is going to cause them to kill themselves.
- 14:30SPEAKER_00: It's just been this myth that has been very pervasive.
- 14:36SPEAKER_00: It's become a meme.
- 14:41SPEAKER_01: I've heard people use direct quotes about the suicide issue, right?
- 14:47SPEAKER_00: Yeah, that's where the, would you rather have a live transgender child or a dead child has come from.
- 14:54SPEAKER_00: And I found in my own survey of detransitioners that about 50% said that they heard
- 15:01SPEAKER_00: that exact line or their family did.
- 15:04SPEAKER_00: So it is very common.
- 15:09SPEAKER_01: But this is a very recent phenomenon, correct?
- 15:11SPEAKER_01: I mean, I don't think there was a thing like 10 or 15 years ago.
- 15:15SPEAKER_01: Where did all this come from?
- 15:18SPEAKER_01: Yeah, I'm just a little curious about that.
- 15:21SPEAKER_00: Well,
- 15:23SPEAKER_00: you know,
- 15:23SPEAKER_00: after gay marriage was sort of legally recognized nationwide in 2015,
- 15:28SPEAKER_00: a lot of these activist organizations like GLAAD and the Human Rights Campaign,
- 15:33SPEAKER_00: I mean,
- 15:33SPEAKER_00: they kind of needed to shift focus in order to keep their doors open and retain funding.
- 15:40SPEAKER_00: So they kind of pivoted to trans rights.
- 15:44SPEAKER_00: I think even...
- 15:46SPEAKER_00: I think Biden,
- 15:47SPEAKER_00: when he was a vice president at one point,
- 15:49SPEAKER_00: said that trans rights were the new civil rights cause.
- 15:52SPEAKER_00: And that's kind of where a lot of this has all been coming from.
- 15:57SPEAKER_00: These organizations, you can't understate their influence.
- 16:02SPEAKER_00: Human rights campaign generates like $50 million a year.
- 16:06SPEAKER_00: And a lot of this has gone into
- 16:11SPEAKER_00: basically propaganda, activist propaganda.
- 16:14SPEAKER_00: That's where all these mentors come from, like trans women are women and trans rights are human rights.
- 16:20SPEAKER_00: That's where all of this information is coming from, is these activist organizations.
- 16:28SPEAKER_00: And what's been leading pediatric gender medicine is activism, not science.
- 16:34SPEAKER_00: And we know that
- 16:35SPEAKER_00: I mean, we have WPATH now.
- 16:37SPEAKER_00: New internal communications from WPATH have just been... Can you tell us what WPATH is, Christina?
- 16:46SPEAKER_00: Yeah.
- 16:48SPEAKER_00: So WPATH is the World Professional Association for Transgender Health.
- 16:54SPEAKER_00: They are a nonprofit organization of self-identified experts in transgender health care.
- 17:01SPEAKER_00: And they are...
- 17:05SPEAKER_00: endorsed by numerous medical organizations and their influential,
- 17:12SPEAKER_00: like standards of care guidelines have been adopted by pediatric gender clinics in
- 17:16SPEAKER_00: the U S and internationally.
- 17:18SPEAKER_00: Like I, I did a review once of all of the pediatric gender clinic websites in 2022.
- 17:24SPEAKER_00: And I
- 17:27SPEAKER_00: vast majority cited WPATH standards of care as the gold standard, that they rely on these standards.
- 17:39SPEAKER_00: So they're incredibly influential.
- 17:42SPEAKER_00: And for a lot of us who have been reporting on
- 17:46SPEAKER_00: this issue have known for a long time that they are,
- 17:50SPEAKER_00: you know,
- 17:51SPEAKER_00: essentially just an activist organization who are kind of looked to as a scientific authority.
- 17:58SPEAKER_00: And these new internal communications that were subpoenaed from WPATH and an Alabama court case, uh,
- 18:09SPEAKER_00: on placing age restrictions on gender-affirming care for minors.
- 18:15SPEAKER_00: They were recently released in the past week, and they're incredibly damning.
- 18:22SPEAKER_00: They show that WPATH tried to cover up evidence that there was no good evidence to
- 18:31SPEAKER_00: support medically transitioning minors,
- 18:33SPEAKER_00: and they've implicated Rachel Levine
- 18:38SPEAKER_00: who that is.
- 18:40SPEAKER_01: Wait, Dr. Rachel?
- 18:41SPEAKER_01: It's Dr. Rachel Levine.
- 18:43SPEAKER_00: Dr. Rachel Levine, the Assistant Secretary of Health's
- 18:46SPEAKER_00: or the U.S.
- 18:47SPEAKER_00: Department of Health and Human Services,
- 18:49SPEAKER_00: who was appointed by the Biden administration,
- 18:52SPEAKER_00: who successfully pressured WPATHs to remove age limitations for minors to receive
- 19:00SPEAKER_00: hormonal and surgical sex trait modifications.
- 19:03SPEAKER_00: In their latest edition of the Standards of Care 8,
- 19:06SPEAKER_00: these are their guidelines that include chapters on sex,
- 19:10SPEAKER_00: medically transitioning minors was released in 2022.
- 19:14SPEAKER_00: So we have emails from around that period now,
- 19:18SPEAKER_00: you know,
- 19:19SPEAKER_00: showing Levine's actions were explicitly politically motivated driven by concerns
- 19:27SPEAKER_00: that age limitations on these interventions would lead to devastating legislation
- 19:34SPEAKER_00: for trans care and
- 19:36SPEAKER_00: So and following the news of Levine's involvement,
- 19:42SPEAKER_00: the Biden administration just this past week announced that they opposed gender
- 19:48SPEAKER_00: affirming surgery for minors,
- 19:49SPEAKER_00: which is very significant because,
- 19:53SPEAKER_00: you know,
- 19:53SPEAKER_00: all of their previous statements,
- 19:55SPEAKER_00: they have supported medical interventions for minors.
- 19:59SPEAKER_00: But, you know, one of the most damning statements, I think, was from a summary judgment that
- 20:05SPEAKER_00: from the Alabama Attorney General,
- 20:08SPEAKER_00: who revealed that WPATH authors of the standards of care had said that their
- 20:16SPEAKER_00: priorities lie in affecting policy and winning lawsuits.
- 20:23SPEAKER_00: And I think this is just incredibly damning.
- 20:26SPEAKER_00: It shows that they're prioritizing activism over children's best interests.
- 20:34SPEAKER_01: So I have a question.
- 20:36SPEAKER_01: You said surgeries.
- 20:38SPEAKER_01: So tell us what you mean by that.
- 20:41SPEAKER_00: Oh, right.
- 20:42SPEAKER_00: The surgeries.
- 20:45SPEAKER_00: For girls, this includes a double mastectomy to remove the breasts.
- 20:51SPEAKER_00: For boys, a breast augmentation.
- 20:55SPEAKER_00: It can also be facial surgeries, general surgeries, and hysterectomies.
- 21:02SPEAKER_00: For boys, this includes like a penile inversion, vaginoplasty.
- 21:09SPEAKER_00: Do you want further explanation on what that is?
- 21:12SPEAKER_01: Sorry, guys.
- 21:13SPEAKER_01: I made a face.
- 21:15SPEAKER_01: But no,
- 21:16SPEAKER_01: I do want explanation because I always avoid,
- 21:19SPEAKER_01: I think a lot of us,
- 21:20SPEAKER_01: we avoid knowing what this means,
- 21:24SPEAKER_01: but we should probably at least know it at least once.
- 21:28SPEAKER_01: Yeah.
- 21:30SPEAKER_00: Well,
- 21:31SPEAKER_00: I mean,
- 21:32SPEAKER_00: not to get too graphic,
- 21:34SPEAKER_00: but they,
- 21:34SPEAKER_00: you know,
- 21:36SPEAKER_00: invert the penis and create a cavity that is supposed to resemble female genitalia.
- 21:46SPEAKER_00: And it's associated with the high risk of complications.
- 21:52SPEAKER_00: Same thing for...
- 21:54SPEAKER_00: kind of um the opposite the phalloplasty for girls involves taking a portion of
- 22:03SPEAKER_00: skin from either their arm or their thigh or someplace like that and basically
- 22:12SPEAKER_00: rolling it up until like
- 22:14SPEAKER_00: something that resembles a phallus and rerouting their urethra.
- 22:21SPEAKER_00: It's associated with extremely high rates of complications.
- 22:27SPEAKER_00: They frequently need revision surgeries.
- 22:32SPEAKER_00: And you're left with just this mass of skin removed from your body.
- 22:38SPEAKER_00: I mean, the pictures are horrific, and I've found that they can be effective in...
- 22:48SPEAKER_00: sort of changing people's mind about all of this.
- 22:51SPEAKER_00: I mean,
- 22:51SPEAKER_00: these surgeries aren't offered to minors,
- 22:53SPEAKER_00: but you often see 19-year-old girls getting them paid for through their medical
- 23:01SPEAKER_00: insurance and just suffering horrific complications after that.
- 23:07SPEAKER_00: It's...
- 23:09SPEAKER_01: Okay, so let me get clear then.
- 23:12SPEAKER_01: Are there ever surgeries for minors,
- 23:14SPEAKER_01: and let's define minors as 18 and under,
- 23:16SPEAKER_01: or no,
- 23:17SPEAKER_01: under 18,
- 23:18SPEAKER_01: for 17 and under?
- 23:19SPEAKER_00: Most frequently, it's girls getting double mastectomies.
- 23:22SPEAKER_00: There is a JAMA surgery study that found between like 2016 and 2019, there were over 1,000 girls
- 23:37SPEAKER_00: of these double mastectomy surgeries performed on minors.
- 23:44SPEAKER_00: But this is likely a significant undercount because they were relying on hospital
- 23:49SPEAKER_00: data rather than private surgery centers.
- 23:53SPEAKER_00: So that's just to give you an idea.
- 23:55SPEAKER_00: So there are thousands of adolescent girls accessing these surgeries.
- 24:01SPEAKER_00: That's the most frequent surgery.
- 24:04SPEAKER_00: Sometimes males get breast augmentations.
- 24:08SPEAKER_00: And for some boys, they are able to get
- 24:13SPEAKER_00: You know, a vaginoplasty surgery at 17.
- 24:19SPEAKER_00: But this isn't as common as the others, as the chest surgeries.
- 24:26SPEAKER_00: But vaginoplasty is never offered to anyone under 18, though.
- 24:31SPEAKER_01: Okay.
- 24:32SPEAKER_01: Okay.
- 24:32SPEAKER_01: So that's good to know.
- 24:35SPEAKER_01: So is it now – so I know the data in the U.S.
- 24:40SPEAKER_01: is a little – so I should say Britain has a national health service.
- 24:44SPEAKER_01: So it's like literal socialized medicine.
- 24:47SPEAKER_01: Doctors are employees of the government.
- 24:50SPEAKER_01: It's kind of an integrated system.
- 24:53SPEAKER_01: It's not like just subsidies or something to insurance or providers or single payer.
- 24:58SPEAKER_01: So they have pretty good data, I think, compared to us in the U.S.
- 25:03SPEAKER_01: where we have a decentralized healthcare system.